Tilray
Prezzo: 4.98Società e modello di business
Tilray is a healthcare company primarily focused on the production and distribution of cannabis products for medical and recreational use. Its core offerings include dried cannabis, oils, and edibles. The company operates in various segments, including medical cannabis, adult-use cannabis, and international markets. Major revenue sources stem from product sales in these segments, with a growing emphasis on expanding its global footprint.
Profilo di investimento
The investment profile of Tilray suggests it may be more suitable for value investors, given its current financial challenges and lack of dividends. The stock exhibits high volatility, indicating potential risks that may deter growth-focused investors. A balanced approach could be considered, but the overall outlook remains cautious due to recent performance metrics.
Metriche fondamentali (sperimentale)
- EPS (TTM) — utile per azione degli ultimi 12 mesi, $
- -18.70 Rischio
- Ricavi QoQ — crescita dei ricavi trimestre su trimestre
- -7.1% ↓
- Sorpresa EPS
- -71.4% peggio del previsto
- Volatilità 20g
- 2.6% stabile
Traccia in portafoglio
Grafico prezzo
| Data | Prima | Dopo | Motivo |
|---|---|---|---|
| 2026-05-08 15:28 | — | Vendi | scenario_deterioration |
| 2026-05-08 05:26 | Vendi | Vendi | scenario_deterioration |
| 2026-03-21 08:01 | Mantieni | Vendi | scenario_deterioration |
| Data | Analista | Action | Target | Prezzo allora |
|---|---|---|---|---|
| 2026-01-20 14:05 | Roth Capital | Target abbassato | 20 → 10 | 8.935 |
| 2026-01-09 12:17 | Industrial Alliance Securities | Target abbassato | 20 → 10 | 9.13 |
| 2025-12-19 12:54 | Bernstein | Target alzato | 1 → 10 | 12.34 |
Ancora nulla